SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: EX-1.1
Date Filed: 2025-08-15
Accession Number: 0001213900-25-077458
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025077458/ea024071103ex1-1_synergy.htm

Chunk 12 of 19
Word Count: 1207
Character Count: 7503

Document Content:

or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.. (e) On or after the date hereof (i) no downgrading shall have occurred in the rating accorded any of the Company’s securities by any “nationally recognized statistical organization,” as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act, and (ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company’s securities. (f) On the Closing Date, the Representative shall have received the favorable opinion and negative assurance letter of Nelson Mullins Riley & Scarborough LLP, counsel to the Company (“Company Counsel”), dated the Closing Date and addressed to the addressed to the Representative as representative of the several Underwriters, in form and substance reasonably satisfactory to the Representative.

(g) At the time this Agreement
is executed, the Representative shall have received a “cold comfort letter” from the Auditor containing statements and information
of the type customarily included in accountants’ comfort letters with respect to the financial statements and certain financial
information contained in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, addressed to the Representative
as representative of the several Underwriters and in form and substance satisfactory to the Representative and counsel to the Underwriters,
dated as of the date of this Agreement.

(h) At each of the Closing Date
and the Option Closing Date, if any, the Representative shall have received from the Auditor a letter, dated as of the Closing Date or
the Option Closing Date, as applicable, addressed to the Representative as representative of the several Underwriters and in form and
substance reasonably satisfactory to the Representative to the effect that the Auditor reaffirms the statements made in the letter furnished
pursuant to Section 6(g).

(i) The Company shall have delivered
to the Representative as representative of the several Underwriters a certificate, dated the Closing Date and any Option Closing Date
(if such date is other than the Closing Date), of its Chief Executive Officer and its Principal Accounting Officer certifying that (i)
such officers have carefully examined the Registration Statement, the Time of Sale Disclosure Package, any Issuer Free Writing Prospectus
and the Final Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as
of the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue statement of a
material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading, and the Time of Sale Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date
if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option
Closing Date if such date is other than the Closing Date), the Final Prospectus and each amendment or supplement thereto, as of the respective
dates thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances in which they were made, not misleading, (ii)
since the effective date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment
to the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, (iii) to the best of their knowledge after
reasonable investigation, as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the representations
and warranties of the Company in this Agreement are true and correct and the Company has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if such date
is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent audited financial statements included
or incorporated by reference in the Time of Sale Disclosure Package, any material adverse change in the financial position or results
of operations of the Company, or any change or development that, singularly or in the aggregate, involves a Material Adverse Change, except
as set forth in the Final Prospectus.

(j) The Company shall have delivered
to the Representative as representative of the several Underwriters a certificate, dated the Closing Date and any Option Closing Date
(if such date is other than the Closing Date), of its Secretary certifying: (i) that each of the Charter and Bylaws is true and complete,
has not been modified and is in full force and effect; (ii) that the resolutions of the Company’s Board of Directors relating to
the Offering are in full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence
between the Company or its counsel and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred
to in such certificate shall be attached as exhibits or annexes to such certificate.

(k) On or before the date of
this Agreement, the Company shall have delivered to the Representative as representative of the several Underwriters executed copies of
the Lock-Up Agreements from each of the Lock-Up Parties.

(l) At the Closing Date, the
Representative’s Warrants and, as to each Option Closing Date, if any, the additional Representative’s Warrants, in definitive
form, in such denominations and registered in such names as the Representative or its designees request, shall have been delivered to
the Representative.

(m) All corporate proceedings
and other legal matters incident to the authorization, form and validity of each of this Agreement, the Representative’s Warrants
and each Lock-Up Agreement, the Shares, the Registration Statement, the Time of Sale Disclosure Package, each Issuer Free Writing Prospectus,
if any, and the Final Prospectus and all other legal matters relating thereto and the transactions contemplated hereby and thereby shall
be reasonably satisfactory in all material respects to counsel to the Underwriters, and the Company shall have furnished to such counsel
all documents and information that they may reasonably request to enable them to pass upon such matters.

(n) The Company shall have furnished
to the Underwriters and their counsel such additional documents, certificates and evidence as the Underwriters or their counsel may have
reasonably requested no more than 3 business days prior to the Closing Date.

If any condition specified
in this Section 6 shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Underwriters
by notice to the Company at any time at or prior to the Closing Date, and such termination shall be without liability of any party to
any other party, except that Section 5(a)(viii), Section 9 and Section 10 shall survive any such termination and remain in full force
and effect.

7. Indemnification and
Contribution.